New Law in New York Mandates Insurance Coverage for Scalp Cooling Therapy

New York Leads With Scalp Cooling Insurance Coverage

Dignitana, a leader in scalp cooling technology, has made a significant announcement regarding a new law in New York that could change the lives of many cancer patients undergoing chemotherapy. Recently signed by Governor Kathy Hochul, this legislation mandates that private health insurers in New York provide coverage for scalp cooling systems aimed at preserving hair during chemotherapy treatments.

What Does the Law Say?

The new law, designated as A38-A/S2063-A, takes effect on January 1, 2026, marking a historic first in the United States. Under this legislation, every insurance policy that provides coverage for cancer chemotherapy must also cover scalp cooling systems, which are essential for patients looking to mitigate chemotherapy-induced hair loss.

This measure received unanimous support in both the State Assembly and Senate, led by sponsors Linda B. Rosenthal and Toby Stavitsky, indicating overwhelming recognition of the importance of this therapy. The passage of this bill reflects an evolving perception towards patient care, particularly in terms of addressing the psychological burdens of hair loss due to medical treatments.

The Impact of DigniCap Scalp Cooling System

Dignitana’s DigniCap Scalp Cooling System is already operational in more than 20 cancer treatment centers across New York State. The implications of this law extend far beyond simple provisions of care; they enhance accessibility for patients and ensure fair reimbursement for healthcare providers administering these therapies.

Fredrik Jonsson, CEO of Dignitana, hailed the legislation as a victory for both patients and providers, stating, "This bill sends a strong message regarding the medical necessity of scalp cooling. We foresee it paving the way to improved insurance coverage in other states as well, allowing us to expand the availability of DigniCap even further."

Advancements in Medical Billing Codes

Adding to this milestone, the American Medical Association has recently upgraded CPT codes related to scalp cooling from temporary to permanent status. This change, set to take effect in January 2026 alongside the New York law, will provide clearer payment guidance to insurers, facilitating smoother processes for reimbursements for scalp cooling treatments.

The Necessity of Scalp Cooling in Chemotherapy

As chemotherapy remains one of the primary treatments for various solid tumors, including breast, ovarian, and prostate cancers, the emotional toll of hair loss cannot be overstated. In New York, breast cancer is prevalent, affecting more than 16,700 individuals each year. The psychological impact of losing one’s hair can diminish self-esteem and overall quality of life during an already challenging period. The DigniCap device, with its advanced thermoelectric cooling technology, is specifically designed to address this side effect by maintaining hair follicles' integrity during treatment periods.

Future Implications

Governor Hochul's signing of this bill signifies a progressive shift in healthcare policies in New York and potentially sets a precedent for further legislation to support patients needing similar coverage elsewhere. As outlined in the bill, insurance coverage may be subject to appropriate deductibles and copayments, maintaining a level of cost-sharing that is consistent with other medical benefits.

In conclusion, this landmark legislation not only enhances patient care but also encourages ongoing discussions regarding the necessity of scalp cooling during cancer treatments. As the legislation unfolds, patient advocates and healthcare professionals alike anticipate broader insurance coverage initiatives to extend beyond New York, ultimately transforming cancer care practices across the nation.